**CLOSING TODAY** INVEST HERE: (https://wefunder.com/onehealthbiosensing).

If you’ve been thinking about it, today is the day. After which we close off access to our community investment round and begin to engage the professional investment community to resource our last push to get to the FDA.

With the explosion in GLP-1 usage, weight loss, health wearables, performance athletic tracking, and consumer health optimization, the One Health CGM is positioned for growth well beyond diabetes.

We’re changing that by creating an ultra-low-cost, daily-dosed CGM powered by AI-enabled lifestyle insights.

We designed it to be beautiful, accurate, flexible, and user-first, so everyone with diabetes can take control of their health. We’re targeting a product launch in 2026, and there is a lot to do before then.

We didn’t invent CGM, but we are re-defining it.

Until now, we’ve funded everything internally. But we believe it’s the right time to invite outside investors to join us as we prepare for FDA submission and a commercial launch. After more than a decade of support from the global diabetes community, we wanted to return the favor by making a small portion of shares in One Health Biosensing available via WeFunder. This is the final opportunity for community members and we’d love to have you on board as a community investor—no matter the amount—for which we hope to deliver you a meaningful potential return. TODAY IS THE LAST DAY TO PARTICIPATE.

I cannot express how grateful I am for the over 140 community investors who have already committed to participate with whatever they felt comfortable with. THANK YOU.

Win Win for everyone.

**CLOSING TODAY** INVEST HERE: (https://wefunder.com/onehealthbiosensing).

The future of diabetes care is with One Health Biosensing.

In good health and warm regards,

Jeff Dachis 
CEO, Chairman, Founder
 One Health Biosensing